Computer-aided detection gains popularity for use in screening and diagnostic mammography

Radiologists have increased their use of computer-aided detection (CAD) in screening and diagnostic mammography, according to a study published in the Journal of the American College of Radiology (2010 Oct;7(10):802-5).

For the study, researchers at Thomas Jefferson University Hospital reviewed codes in records from 2004 to 2008 for screening and diagnostic mammography, as well as screening and diagnostic CAD.

The results of the study revealed that in 2008, of the screening mammograms performed, 74% involved the use of CAD, compared to 39% in 2004. “By 2008, CAD was used in about three-quarters of all screening exams and half of all diagnostic exams,” said Vijay Rao, MD, lead author of the study. “The use of CAD is controversial, while some support it and others are critical of it. Nonetheless, while there remains debate over the efficacy of CAD, it is apparent that radiologists are increasingly utilizing this technology and that it is becoming standard practice in breast diagnosis." ONA

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs

More in Web Exclusives

Everolimus overcomes trastuzumab resistance in HER2+ early breast cancer

Some patients with early breast cancer had a benefit in clinical response rate when everolimus was added to trastuzumab treatment, though the benefit was statistically nonsignificant. These puzzling results suggested that this benefit was independent of the molecular pathways that could be expected to be ...

Basal-cell carcinoma targeted by new deoxyribozyme drug

A new class of drugs targeting the genetic material of skin cancer has been successfully tested in humans for the first time. This opens the way to new treatments for a range of conditions from skin cancers to eye diseases.

FDA wants warning labels on tanning devices

The FDA is proposing that indoor tanning beds and booths carry labels that warn minors not to use these products.